|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Z, Zhang Y, Franzin L, Cormier JN,
Chan W, Xu H and Du XL: Trends and variations in breast and
colorectal cancer incidence from 1995 to 2011: A comparative study
between Texas Cancer Registry and National Cancer Institute's
Surveillance, Epidemiology and End Results data. Int J Oncol.
46:1819–1826. 2015.PubMed/NCBI
|
|
3
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ramasamy TS, Ayob AZ, Myint HH,
Thiagarajah S and Amini F: Targeting colorectal cancer stem cells
using curcumin and curcumin analogues: Insights into the mechanism
of the therapeutic efficacy. Cancer Cell Int. 15:962015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kang H, O'Connell JB, Maggard MA, Sack J
and Ko CY: A 10-year outcomes evaluation of mucinous and
signet-ring cell carcinoma of the colon and rectum. Dis Colon
Rectum. 48:1161–1168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P,
Yuan Z, Deng Y, Wang J, Chen D, et al: Increased urothelial cancer
associated 1 is associated with tumor proliferation and metastasis
and predicts poor prognosis in colorectal cancer. Int J Oncol.
47:1329–1338. 2015.PubMed/NCBI
|
|
8
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao MY, Kuo MY, Lu TY, Wang YP and Wu HC:
Generation of an anti-EpCAM antibody and epigenetic regulation of
EpCAM in colorectal cancer. Int J Oncol. 46:1788–1800.
2015.PubMed/NCBI
|
|
11
|
Weaver AM: Cortactin in tumor
invasiveness. Cancer Lett. 265:157–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rodrigo JP, Álvarez-Alija G, Menéndez ST,
Mancebo G, Allonca E, García-Carracedo D, Fresno MF, Suárez C and
García-Pedrero JM: Cortactin and focal adhesion kinase as
predictors of cancer risk in patients with laryngeal premalignancy.
Cancer Prev Res (Phila). 4:1333–1341. 2011. View Article : Google Scholar
|
|
13
|
Weed SA, Karginov AV, Schafer DA, Weaver
AM, Kinley AW, Cooper JA and Parsons JT: Cortactin localization to
sites of actin assembly in lamellipodia requires interactions with
F-actin and the Arp2/3 complex. J Cell Biol. 151:29–40. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bryce NS, Clark ES, Leysath JL, Currie JD,
Webb DJ and Weaver AM: Cortactin promotes cell motility by
enhancing lamellipodial persistence. Curr Biol. 15:1276–1285. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hill A, McFarlane S, Mulligan K, Gillespie
H, Draffin JE, Trimble A, Ouhtit A, Johnston PG, Harkin DP,
McCormick D, et al: Cortactin underpins CD44-promoted invasion and
adhesion of breast cancer cells to bone marrow endothelial cells.
Oncogene. 25:6079–6091. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hirakawa H, Shibata K and Nakayama T:
Localization of cortactin is associated with colorectal cancer
development. Int J Oncol. 35:1271–1276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chi Y, Huang S, Liu M, Guo L, Shen X and
Wu J: Cyclin D3 predicts disease-free survival in breast cancer.
Cancer Cell Int. 15:892015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T,
Yiin JJ, Lu S, Keezer S, Fenton T, et al: Activation of Rac1 by
Src-dependent phosphorylation of Dock180(Y1811) mediates
PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin
Invest. 121:4670–4684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Yang L, Fu H, Yan J, Wang Y, Guo H,
Hao X, Xu X, Jin T and Zhang N: Association between Gαi2 and
ELMO1/Dock180 connects chemokine signalling with Rac activation and
metastasis. Nat Commun. 4:17062013. View Article : Google Scholar
|
|
20
|
Jing F, Kim HJ, Kim CH, Kim YJ, Lee JH and
Kim HR: Colon cancer stem cell markers CD44 and CD133 in patients
with colorectal cancer and synchronous hepatic metastases. Int J
Oncol. 46:1582–1588. 2015.PubMed/NCBI
|
|
21
|
Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai
Y, Zhang X, Sun YT, Zhan QM, Wu M, et al: Amplification and
overexpression of CTTN (EMS1) contribute to the metastasis of
esophageal squamous cell carcinoma by promoting cell migration and
anoikis resistance. Cancer Res. 66:11690–11699. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee MS, Kim S, Kim BG, Won C, Nam SH, Kang
S, Kim HJ, Kang M, Ryu J, Song HE, et al: Snail1 induced in breast
cancer cells in 3D collagen I gel environment suppresses cortactin
and impairs effective invadopodia formation. Biochim Biophys Acta.
1843:2037–2054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kozyreva VK, McLaughlin SL, Livengood RH,
Calkins RA, Kelley LC, Rajulapati A, Ice RJ, Smolkin MB, Weed SA
and Pugacheva EN: NEDD9 regulates actin dynamics through cortactin
deacetylation in an AURKA/HDAC6-dependent manner. Mol Cancer Res.
12:681–693. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Côté JF and Vuori K: GEF what? Dock180 and
related proteins help Rac to polarize cells in new ways. Trends
Cell Biol. 17:383–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laurin M, Huber J, Pelletier A, Houalla T,
Park M, Fukui Y, Haibe-Kains B, Muller WJ and Côté JF: Rac-specific
guanine nucleotide exchange factor DOCK1 is a critical regulator of
HER2-mediated breast cancer metastasis. Proc Natl Acad Sci USA.
110:7434–7439. 2013. View Article : Google Scholar : PubMed/NCBI
|
